AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
ASTRAZENECA PLC
Financials through Q2 FY2026, quarter ended Jun 30, 2026
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026
- Market cap
- $255.76B
- P/E (TTM)
- 25.1
- Dividend yield
- 1.91%
Community
Notes and questions about Astrazeneca from other investors
No posts about AZN yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.